Navigation Links
VNUS Medical Technologies to Report Fourth-Quarter 2008 Results and Webcast Teleconference on February 10
Date:1/26/2009

SAN JOSE, Calif., Jan. 26 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, announced today that it plans to report its financial results for the fourth quarter ended December 31, 2008, after the close of market on February 10.

VNUS plans to host its regular quarterly teleconference at 2:00 p.m. PT / 5:00 p.m. ET on February 10. This call will also be webcast live for investors and archived on the company's website at http://www.vnus.com.

How to Access the Live Teleconference

To participate, please dial (303) 262-2137 approximately 5-10 minutes before the teleconference is scheduled to begin. The operator will take your name and connect your line with the meeting. A phone replay will be available for seven days after the live call at (303) 590-3000, code 11124466#.

How to Access the Teleconference Webcast

Go to the home page of the VNUS investor relations website at http://ir.vnus.com/ and click on the webcast icon. From this site, you can listen to the teleconference, assuming that your computer system is configured properly.

About VNUS Medical Technologies, Inc.

VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux, a progressive condition caused by incompetent vein valves in the leg. VNUS sells the Closure system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to treat diseased veins through the application of temperature-controlled RF energy. For more information, please visit the corporate webs
'/>"/>

SOURCE VNUS Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... News) -- A new Canadian study has uncovered an ... less likely than men to get trauma center care ... to health care services in general have been recognized ... disparities extend to the treatment of severe injuries in ... at Sunnybrook Health Sciences Centre and the University of ...
(Date:5/20/2013)... 2013 The International Distance Skateboard Association has ... for the best long distance skaters to attend and compete. ... a venue of raising money for our local Boys & ... IDSA is the authority on long distance races throughout the ... event is safe and organized for all who want to ...
(Date:5/20/2013)... 2013 CosmosID, a leading data mining solutions company for ... collaboration results on analysis of labeling claims for the ... , The Food and Drug Administration (FDA) and CosmosID ... probiotics, four of which have been reported at the ... tests was to compare the identity of species and ...
(Date:5/20/2013)... Dalton, Georgia (PRWEB) May 20, 2013 ... fields, has significantly expanded its presence in the Midwest ... office in Kansas City, Missouri. Sporturf Midwest is ... focus on Iowa, Nebraska, Missouri and Kansas. , ... Sporturf has not really been in before,” noted Shonk. ...
(Date:5/20/2013)... Online education provides the convenience, flexibility ... not offer. According to the American Heart Association, ... classroom learning to eLearning due to changing economic ... maximize training budgets, but it is also proven ... 25–60%. A higher retention of content is probable, ...
Breaking Medicine News(10 mins):Health News:Women Less Likely to Get Trauma Center Care After Injury: Study 2Health News:CosmosID unveils new tool for faster, specific and accurate testing of probiotics products 2Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses 2
... TORONTO, February 16, 2011 − One of the tough challenges ... how to parent the surviving children, and the task begins ... From the moment their child dies, parents are faced with ... loss of a child and the ongoing, daily demands from ...
... By Serena Gordon HealthDay Reporter , WEDNESDAY, ... Physicians has released new guidelines recommending that doctors not ... sugar levels in patients in medical or surgical intensive ... with diabetes and without the condition. The college recommends ...
... screening and treatment of genitourinary cancers were released today in ... February 17-19, 2011, at the Orlando World Center Marriott in ... in a media presscast (press briefing via live webcast): ... cancer death for men with low initial PSAs: A large ...
... with Alzheimer,s disease or other dementias, and their families, ... plan for the patient,s progressive loss of ability to ... physician at the San Francisco VA Medical Center and ... patient is diagnosed with Alzheimer,s disease or dementia, the ...
... Men with prostate cancer may be twice as likely to have ... 20 than those without prostate cancer, a new French study suggests. ... 40s do not appear to face a similar boost in prostate ... do not face a higher risk of developing the cancer at ...
... , TUESDAY, Feb. 15 (HealthDay News) -- A review of ... Americans pop at the first sign of a cold may, in ... conducted by a team in India and published in the ... people have to stay away from work or school. "This ...
Cached Medicine News:Health News:Parenting after the death of a child a difficult balancing act: York U study 2Health News:In-Hospital Blood Sugar Levels Should Be Higher: Report 2Health News:In-Hospital Blood Sugar Levels Should Be Higher: Report 3Health News:Research presented at 2011 GU Cancers Symposium highlights advances in treatment of prostate cancer 2Health News:Financial planning a key but neglected component of Alzheimer's care, say researchers 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 3Health News:Zinc May Help Ease Common Cold: Analysis 2
(Date:5/17/2013)... 17, 2013 Medical devices are any medical ... product. In light of their different mechanisms, actions and ... more complicated than drug trails due to their unique ... instead of evaluating both safety and efficacy (which is ... is the same as the SFDA) evaluate MDs for ...
(Date:5/17/2013)... DIEGO , May 17, 2013  Sorrento ... that its Fast-Track Advanced Technology Small Business Technology ... Institute of Allergy and Infectious Diseases (NIAID), a ... supporting the development of novel human antibody therapeutics ... aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... , May 17, 2013  Technology advances ... communicate internally. Faced with a constantly evolving communication ... and tactics for communicating with internal executives. It ... all the strategies, tactics and tools that are ... In a new study, Best Practices, LLC explores ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2
... VANCOUVER, British Columbia, June 21, 2011 Enox Biopharma, Inc. ... East Investment in Innovation Conference on Wednesday, June 22 at ... Hyatt Regency Hotel in Boston. The IN3 ... and networking meeting. The meeting is designed to provide exposure ...
... Robbins & Myers, Inc. (NYSE: RBN ... approved its regular quarterly cash dividend payment of $0.045 ... 2011 to shareholders of record as of July 8, ... leading supplier of engineered equipment and systems for critical ...
Cached Medicine Technology:Enox Biopharma, Inc. Will Present at IN3 East Investment in Innovation Conference 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: